Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Guidelines for stage I to III melanoma].
Guillot B, Dalac S, Denis M, Dupuy A, Emile JF, De La Fouchardiere A, Hindie E, Jouary T, Lassau N, Mirabel X, Piperno Neumann S, De Raucourt S, Vanwijck R. Guillot B, et al. Among authors: lassau n. Bull Cancer. 2016 Sep;103(9):743-52. doi: 10.1016/j.bulcan.2016.06.002. Epub 2016 Jul 22. Bull Cancer. 2016. PMID: 27456259 French. No abstract available.
[Recommendations for the management of GIST patients].
Blay JY, Landi B, Bonvalot S, Monges G, Ray-Coquard I, Duffaud F, Bui NB, Bugat R, Chayvialle JA, Rougier P, Bouché O, Bonichon F, Lassau N, Vanel D, Nordlinger B, Stoeckle E, Meeus P, Coindre JM, Scoazec JY, Emile JF, Ranchère D, Le Cesne A. Blay JY, et al. Among authors: lassau n. Bull Cancer. 2005 Oct;92(10):907-18. Bull Cancer. 2005. PMID: 16266874 Free article. French.
[Targeted treatments: which imaging?].
Lassau N, Chebil M, Benatsou B, Chami L, Roche A. Lassau N, et al. Bull Cancer. 2008 Oct;95(10):989-93. doi: 10.1684/bdc.2008.0721. Bull Cancer. 2008. PMID: 19004731 Free article. French.
[Update to the recommendations for management of melanoma stages I to III].
Guillot B, Dalac S, Denis MG, Dupuy A, Emile JF, De La Fouchardière A, Hindie E, Jouary T, Lassau N, Mirabel X, Piperno Neumann S, De Raucourt S, Vanwijck R. Guillot B, et al. Among authors: lassau n. Ann Dermatol Venereol. 2016 Oct;143(10):629-652. doi: 10.1016/j.annder.2016.07.001. Epub 2016 Aug 12. Ann Dermatol Venereol. 2016. PMID: 27527567 Review. French.
French updated recommendations in Stage I to III melanoma treatment and management.
Guillot B, Dalac S, Denis MG, Dupuy A, Emile JF, De La Fouchardiere A, Hindie E, Jouary T, Lassau N, Mirabel X, Piperno Neumann S, De Raucourt S, Vanwijck R. Guillot B, et al. Among authors: lassau n. J Eur Acad Dermatol Venereol. 2017 Apr;31(4):594-602. doi: 10.1111/jdv.14064. Epub 2017 Jan 24. J Eur Acad Dermatol Venereol. 2017. PMID: 28120528
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.
Escudier B, Lassau N, Angevin E, Soria JC, Chami L, Lamuraglia M, Zafarana E, Landreau V, Schwartz B, Brendel E, Armand JP, Robert C. Escudier B, et al. Among authors: lassau n. Clin Cancer Res. 2007 Mar 15;13(6):1801-9. doi: 10.1158/1078-0432.CCR-06-1432. Clin Cancer Res. 2007. PMID: 17363536 Clinical Trial.
180 results